Skip to Main Content

Author Details

Peter J Selby
College of Agriculture and Life Sciences, Cornell University
1977
424
81
PMIDPaper TitleJournal TitlePublished Year
36815791Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma.Clin Cancer Res2023
37695662Benefits of Mentoring in Oncology Education for Mentors and Mentees: Pre-Post Interventional Study of the British Oncology Network for Undergraduate Societies' National Oncology Mentorship Scheme.JMIR Med Educ2023
37971715Data sharing and ontology use among agricultural genetics, genomics, and breeding databases and resources of the Agbiodata Consortium.Database (Oxford)2023
34904181Stability of health-related quality of life and morbidity burden from 18 months after diagnosis of prostate cancer: results of a UK-wide population-based outcome cohort.Support Care Cancer2022
35365520Development and validation of multivariable machine learning algorithms to predict risk of cancer in symptomatic patients referred urgently from primary care: a diagnostic accuracy study.BMJ Open2022
33772027Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy.Nat Commun2021
35559911The European Code of Cancer Practice.J Cancer Policy2021
33642238Experiences of Support for Sexual Dysfunction in Men With Prostate Cancer: Findings From a U.K.-Wide Mixed Methods Study.J Sex Med2021
31411979Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015.Eur Urol Oncol2020
32033669AUTHOR REPLY.Urology2020
32065691Decision regret in men living with and beyond nonmetastatic prostate cancer in the United Kingdom: A population-based patient-reported outcome study.Psychooncology2020
32034147APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy.Nat Commun2020
31705948UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time.Urology2020
33002843Influence of deprivation and rurality on patient-reported outcomes of men living with and beyond prostate cancer diagnosis in the UK: A population-based study.Cancer Epidemiol2020
32995252Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group.J Bone Oncol2020
32390008Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.Br J Cancer2020
32151466ECCO Essential Requirements for Quality Cancer Care: Prostate cancer.Crit Rev Oncol Hematol2020
32398335Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer.BMJ Open2020
30661923Rectal cancer in old age -is it appropriately managed? Evidence from population-based analysis of routine data across the English national health service.Eur J Surg Oncol2019
31445441ECCO Essential Requirements for Quality Cancer Care: Primary care.Crit Rev Oncol Hematol2019
31071525Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study.Cancer Epidemiol2019
30713036Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.Lancet Oncol2019
31099640The Value and Future Developments of Multidisciplinary Team Cancer Care.Am Soc Clin Oncol Educ Book2019
31060822Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.Eur Urol2019
31115843Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.Qual Life Res2019
30940643Suboptimal T-cell Therapy Drives a Tumor Cell Mutator Phenotype That Promotes Escape from First-Line Treatment.Cancer Immunol Res2019
30605491The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.PLoS Med2019
30426503Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.J Pathol2019
27902444Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer.Gut2018
29853305Corrigendum re "Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma" [Eur Urol 2017;72:747-54].Eur Urol2018
30038798Taking patient reported outcomes centre stage in cancer research - why has it taken so long?Res Involv Engagem2018
30294666APOBEC3 Mediates Resistance to Oncolytic Viral Therapy.Mol Ther Oncolytics2018
30303111The impact of Brexit on UK cancer research.Lancet Oncol2018
29489050Urinary, bowel and sexual health in older men from Northern Ireland.BJU Int2018
29428868Mapping the cancer patient information landscape: A comparative analysis of patient groups across Europe and North America.Eur J Cancer2018
29298869Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.Sci Transl Med2018
29316711Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study.Diagnostics (Basel)2018
27779616Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy.Gene Ther2017
28275394The potential consequences for cancer care and cancer research of Brexit.Ecancermedicalscience2017
29038298Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence.Cancer Immunol Res2017
28598434Genome-wide association study identifies multiple risk loci for renal cell carcinoma.Nat Commun2017
28848664The European Cancer Patient's Bill of Rights, update and implementation 2016.ESMO Open2017
28797570Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.Eur Urol2017
28547002Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion.Mol Ther Oncolytics2017
27797935High hospital research participation and improved colorectal cancer survival outcomes: a population-based study.Gut2017
26921289Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents.Oncologist2016
26409567Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling.Neuro Oncol2016
27933315Immunogenicity of self tumor associated proteins is enhanced through protein truncation.Mol Ther Oncolytics2016
27927667Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study.BMJ Open2016
27920029The Association of Cancer Physicians responds to "Cancer drugs, survival, and ethics".BMJ2016
  • 1 - 50 of 424

Recommended Authors

Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 4
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 8
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 0
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 2
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 3
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 2
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Career Start Year 1993
Number of shared co-authors 1
Vera J Suman
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
Janet A Dunn
Warwick Clinical Trials Unit, University of Warwick
Career Start Year 1991
Number of shared co-authors 11
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 0
Val??rie Laurence
Institut Curie
Career Start Year 1990
Number of shared co-authors 8
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 5
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 6
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 2
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Paul Harnett
Westmead Clinical School, University of Sydney
Career Start Year 1986
Number of shared co-authors 7
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 2
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 1
Helen J Ross
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 5
Fabien Calvo
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 6
Wolfgang E Berdel
University Hospital Munster
Career Start Year 1976
Number of shared co-authors 0
Bengt Glimelius
Uppsala University
Career Start Year 1974
Number of shared co-authors 12
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Ronald de Wit
Erasmus MC Cancer Institute
Career Start Year 1972
Number of shared co-authors 3
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Career Start Year 1967
Number of shared co-authors 0

Collaborators

Alan Melcher
The Institute of Cancer Research
Co-authored papers 56
Susan A Burchill
Leeds Institute of Medical Research, St. James's University Hospital
Co-authored papers 15
Mark Lawler
Queens University Belfast Belfast
Co-authored papers 13
Ian Banks
ACP Strategy Drafting Group Supporting Chapter Author University of Leeds
Co-authored papers 9
Jianhe Peng
Co-authored papers 8
Douglas F Easton
University of Cambridge
Co-authored papers 8
Kristian Hveem
Co-authored papers 6
Jan Lubinski
Pomeranian Medical University
Co-authored papers 6
Meredith Yeager
Frederick National Laboratory for Cancer Research
Co-authored papers 6
Jolanta Lissowska
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 6
Zhaoming Wang
St Jude Children's Research Hospital
Co-authored papers 6
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Hélène Blanché
Co-authored papers 6
Demetrius Albanes
Co-authored papers 5
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 5
Stephanie J Weinstein
Co-authored papers 5
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 4
Mark Lathrop
Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University
Co-authored papers 4
G M Lathrop
Co-authored papers 4
Adrian L Harris
University of Oxford
Co-authored papers 4
Loren Lipworth
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Co-authored papers 4
Julie E Buring
Co-authored papers 4
John Michael Gaziano
VA Boston Healthcare System
Co-authored papers 4
Richard D Unwin
Co-authored papers 4
Matthew L Freedman
Dana-Farber Cancer Institute
Co-authored papers 4
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 4
Victoria A Jennings
Leeds Institute of Medical Research at St James's, University of Leeds
Co-authored papers 4
Satu Männistö
Co-authored papers 4
Harry Campbell
Co-authored papers 4
Sunil R Lakhani
University of Queensland
Co-authored papers 4
Release 1.2